COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

Loss of olfaction is one of the symptoms most commonly reported by patients with
coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high …

Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …

The coronavirus disease 2019 (COVID-19) pandemic is wreaking havoc on public-health
and economic systems worldwide. Among the several neurological symptoms of patients …

The COVID-19 pandemic continues to cause severe global disruption, resulting in significant
excess mortality, overwhelming healthcare systems, and imposing substantial social and …

Introduction: COVID-19 can be associated with a variety of longer-lasting impairments that
can have a significant impact on patients' quality of life (QoL). While this is well described in …

Purpose of Review A number of sequelae after acute coronavirus disease 2019 (COVID-19)
significantly affect the quality of life of patients. The chemosensory disorders including …

Background There is evidence that chemosensory dysfunctions, including smell and taste
disorders, are common findings in patients with SARS-CoV-2 infection. However, the …

Background While the short-term symptoms of post-COVID syndromes (PCS) are well-
known, the long-term clinical characteristics, risk factors and outcomes of PCS remain …